Biocartesian

Drug discovery and disease research are limited because existing tissue analysis tools detect less than 1% of abnormal molecules and lack detailed spatial insight.

Biocartesian combines microscopy with novel chemistries to generate high-resolution digital molecular maps of tissues, detecting ~50× more molecules than current methods.

Pharma companies and biomedical researchers who need spatial molecular profiling of diseased tissues for target discovery and therapy development.